NVO

Novo Nordisk A/S (NVO)

Last Price$86.30.8%
Market Cap$384.7B
LTM Quick ratio
0.7x
5Y avg
0.7x
Biotechnology industry median
4.1x
Stock quality & Intrinsic value
7/10
(0.2%) overvalued

Novo Nordisk A/S Quick ratio

Annual
Quarterly
LTM
Industry median
Company stand-alone
NVO
Healthcare
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Quick ratio
1.2x
1.1x
1.1x
1.4x
1.5x
1.5x
1.4x
1.4x
1.4x
1.0x
1.0x
0.9x
0.9x
1.0x
0.8x
0.8x
0.6x
0.6x
0.7x
0.6x
NVO
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for NVO and see if it's the right time to invest.
Dive in

Novo Nordisk A/S (NVO) Quick ratio comparison analysis

Crunching data... Almost there!

NVO key stats

USD
DKK
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

1) What is Novo Nordisk A/S's Quick ratio?

As of today, Microsoft Corp's last 12-month Quick ratio is 0.7x, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Quick ratio for Novo Nordisk A/S have been 0.6x over the past three years, and 0.7x over the past five years.

2) Is Novo Nordisk A/S's Quick ratio Good?

As of today, Novo Nordisk A/S's Quick ratio is 0.7x, which is lower than industry median of 4.1x. It indicates that Novo Nordisk A/S's Quick ratio is Bad.

3) How does Novo Nordisk A/S's Quick ratio compare to its peers?

As of today, Novo Nordisk A/S's Quick ratio is 0.7x, which is lower than peer median of 3.2x. The list of peers includes BNTX, GMAB, REGN, UTHR, MRNA, ALNY, VRTX, INCY, BGNE, ARGX.